These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21136240)
1. [Antineoplastic drug-induced extravasation]. de Wit M Med Klin (Munich); 2010 Nov; 105(11):812-24. PubMed ID: 21136240 [No Abstract] [Full Text] [Related]
2. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1. Robinet G; Thomas P; Breton JL; Léna H; Gouva S; Dabouis G; Bennouna J; Souquet PJ; Balmes P; Thiberville L; Fournel P; Quoix E; Riou R; Rebattu P; Pérol M; Paillotin D; Mornex F Ann Oncol; 2001 Jan; 12(1):59-67. PubMed ID: 11249050 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of combined chemotherapy with vinorelbine, ifosfamide and cisplatin in the treatment of metastatic non-small cell bronchial carcinoma]. Boutemy M; Mispelaere D; Krzisch C; Jounieaux V Rev Mal Respir; 2005 Jun; 22(3):413-9. PubMed ID: 16227927 [TBL] [Abstract][Full Text] [Related]
4. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients. Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899 [TBL] [Abstract][Full Text] [Related]
6. Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer. Kobayashi M; Matsui K; Hirashima T; Nitta T; Sasada S; Tada T; Minakuchi K; Furukawa M; Ogata Y; Kawase I Int J Clin Oncol; 2006 Aug; 11(4):314-9. PubMed ID: 16937306 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous recall phenomenon with vinorelbine. Gómez-Ulloa D; Bundó AV; Antonio JM; Arriola E; Conde-Estévez D Ann Pharmacother; 2011 Sep; 45(9):1168-9. PubMed ID: 21862715 [No Abstract] [Full Text] [Related]
8. Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer. Quantin X; Khial F; Reme-Saumon M; Michel FB; Pujol JL Lung Cancer; 1999 Oct; 26(1):35-9. PubMed ID: 10574679 [TBL] [Abstract][Full Text] [Related]
9. Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist. Van Houtte P Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):533-5. PubMed ID: 9336128 [No Abstract] [Full Text] [Related]
10. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study. Beckmann G; Fietkau R; Huber RM; Kleine P; Schmidt M; Semrau S; Aubert D; Fittipaldo A; Flentje M Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369 [TBL] [Abstract][Full Text] [Related]
11. The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer. Myerson JS; Faria A; Puglisi M; Starling N; Popat S; O'Brien ME Lung Cancer; 2010 Sep; 69(3):365-6. PubMed ID: 20655614 [No Abstract] [Full Text] [Related]
12. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). Wakelee HA; Middleton G; Dunlop D; Ramlau R; Leighl N; Hao D; Lopez-Anaya A; Zatloukal P; Jacobs CD Cancer Chemother Pharmacol; 2012 Mar; 69(3):815-24. PubMed ID: 22057854 [TBL] [Abstract][Full Text] [Related]
13. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. Winton T; Livingston R; Johnson D; Rigas J; Johnston M; Butts C; Cormier Y; Goss G; Inculet R; Vallieres E; Fry W; Bethune D; Ayoub J; Ding K; Seymour L; Graham B; Tsao MS; Gandara D; Kesler K; Demmy T; Shepherd F; ; N Engl J Med; 2005 Jun; 352(25):2589-97. PubMed ID: 15972865 [TBL] [Abstract][Full Text] [Related]
14. Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Hoffman PC; Cohen EE; Masters GA; Haraf DJ; Mauer AM; Rudin CM; Krauss SA; Huo D; Vokes EE Lung Cancer; 2002 Oct; 38(1):65-71. PubMed ID: 12367795 [TBL] [Abstract][Full Text] [Related]
15. Skin necrosis from extravasation of vinorelbine. Moreno de Vega MJ; Dauden E; Abajo P; Bartolome B; Fraga J; Garcia-Diez A J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):488-90. PubMed ID: 12428844 [TBL] [Abstract][Full Text] [Related]
16. A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma. Chen YM; Yu CJ; Yang CH; Perng RP; Tsai CM; Shih JF; Cheng AL; Lefresne F; Barbier M; Pouget JC; Yang PC Lung Cancer; 2007 Apr; 56(1):89-95. PubMed ID: 17208330 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. Arriagada R; Bergman B; Dunant A; Le Chevalier T; Pignon JP; Vansteenkiste J; N Engl J Med; 2004 Jan; 350(4):351-60. PubMed ID: 14736927 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study. Cigolari S; Curcio C; Maiorino A; Sessa R; Cioffi A; Massimo M Anticancer Res; 2003; 23(2C):1803-9. PubMed ID: 12820462 [TBL] [Abstract][Full Text] [Related]
19. Intramedullary metastases due to non microcytic lung carcinoma. Maciá Escalante S; Martínez Ortiz MJ; Guillén Ponce C; Rodríguez Lescure A; Gallego Plazas J; Carrato Mena A Clin Transl Oncol; 2006 Jun; 8(6):459-60. PubMed ID: 16790402 [No Abstract] [Full Text] [Related]
20. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]